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The objective of the present investigation was to evaluate potential of nanoemulsions as a coating material for the tablets.
The nanoemulsion of size less than 100nm was prepared using a simple and low-energy spontaneous emulsiﬁcation method.
Conventionaltabletscontainingtheophyllineasamodelhydrophilicdrugwereprepared.Thetheophyllinetabletswerecoatedwith
the nanoemulsion using a ﬂuid bed coater. The eﬀect of diﬀerent levels of the nanoemulsion coating on the theophylline release
was evaluated. The theophylline tablets containing diﬀerent levels of the nanoemulsion coating could be successfully prepared.
Interestingly, the coating of tablet with the nanoemulsion resulted in zero-order release of theophylline from the tablets. The
noncoated theophylline tablets release the entire drug in less than 2 minutes, whereas nanoemulsion coating delayed the release
of theophylline from tablets. This investigation establishes the proof of concept for the potential of nanoemulsions as a coating
material for tablets.
1.Introduction
The design and development of simple systems with the
aim of delivery and controlled release of hydrophilic drugs
administered through oral route are still a challenge. Com-
paredtoclassicaldosageforms,thegoalsforthedevelopment
of such systems include maintaining of blood levels for
the drug in a therapeutic window for a desired period.
Such controlled drug-delivery systems present considerable
advantage over conventional dosage forms, but they involve
carrying out speciﬁc and complex technologies [1–12].
The most widespread systems giving modiﬁed releases are
hydrophilic matrix carriers or hydrophilic coating matrix
(e.g., on tablets). Pharmaceutically available polymers such
as polymethacrylates (Eudragit RS100 and Eudragit S100),
ethyl cellulose (EC), and hydroxypropyl methylcellulose
(HPMC), as a single or mixed composition, are largely
studied and used for this purpose [13–18]. The modiﬁed
drug releases are actually a combination of several physical
processesincluding,diﬀusion,polymerswelling,dissolution,
or erosion [19–22].
The literature generally reports investigations on the
impacts of the formulation parameters—for example, coat-
ings levels, nature of solvent, nature of polymer and plasti-
cizer, polymer particle size, polymer weight, degree of substi-
tution and polymer concentration [5, 16–18, 23–26],and the
processing parameters—air pressure and temperature on the
physicochemical properties of the coated ﬁlm, that is to say,
onthedrugreleaseproﬁles.Inthiscontext,ithasbeenshown
thatthedrugreleaseismainlyrelatedtothephysicalbehavior
of the coating materials with regards to the release media
(for instance, tensile strength, contact angle, and solubility)
[5, 17, 27, 28]. It is easily understandable, since the drug
release,inthesecoatedsystems,arisesafterthedrugsolvation
and diﬀusion, and thus after the gradual swelling (i) ﬁrstly
of the coating polymer and (ii) secondly of the vehicle (like
a tablet). Accordingly, the solvated drug is released (e.g.,
by diﬀusion) through this swollen system towards the bulk
phase. It is to be noted here that the swelling kinetics of the
coating polymer is of prime importance and must be fast
enough to prevent the tablet disintegration during this ﬁrst
phase of the process.2 Journal of Drug Delivery
The particular case of zero order is of real interest, since
it confers to the system, the ability to deliver a drug at a
constant rate. Hence, a steady amount of drug is released
over time, which, on the one hand, minimizes potential
peak/trough ﬂuctuations and side eﬀects, and on the other
hand, maximizes the time for which the drug concentrations
remain within the therapeutic window. With the examples
of hydrophilic matrix presented above, zero-order release
proﬁles are the direct consequences of the Fickian diﬀusion
of the drugs through a membrane (Fick’s ﬁrst law).
The zero-order release can also be induced by a speciﬁc
swellablepolymer coating technology. The numerous studies
reported on these domains are focused on the formulation
and processing parameters described above, for a single
polymer or blend of various polymers. However, as a
constantfactor,thesetechnologiesstillusepolymerstocreate
such a barrier between the drug and release media. This
is precisely the novelty of our approach, since herein, we
propose a new method, applicable to tablets to provide
zero-order drug release proﬁles, by using lipids instead of
polymers. This paper presents tablet lipid coating, based on
a speciﬁc nanotechnology (lipid nanoemulsions), followed
by a study of hydrophilic drug releases (theophylline),
disclosure, and modeling the release mechanisms. The idea
was to coat the tablets, by a lipid species, in order to create
a lipid coating or lipid adsorbed layer, serving as barrier
against the hydrophilic drug leakage. This was originally
carried out by using a ﬂuid-bed apparatus for spray-coating
thetabletswithanaqueoussuspensionoflipidnanodroplets,
so-called nanoemulsions. Now, a question arises: why to
use lipid nanosuspension for this purpose? The answer is
simple, since (i) the lipid nanosuspension is able to penetrate
the tablet microporous matrix, (ii) the huge homogeneity
of these nanoemulsiﬁed dispersions will provide a very
homogeneous coating, (iii) lipid nanoemulsions are very
stable, easy to prepare and are fully compatible with the
spray-coating technologies, and ﬁnally, (iv) the nanoemul-
sions formulated by low-energy methods (the case here) are
very simple systems adaptable to industrial scaling-up and
purposes.
Nanoemulsions are emulsions, in which the size of
oil-in-water droplets are typically in nanorange, ranging
between 20 and 300nm [29–31]. The main advantage of
nanoemulsions, as in our case, is their stability. Actually,
due to their small size, the oil droplets behave typically as
Brownian particles and do not interact with each others,
resulting in their stability, for up to several months [32–
34].Accordingly,nanoemulsionsareconsideredasparticular
tools for chemical and pharmaceutical applications, for
example, allowing poorly soluble species in water to disperse
in a stable way. Another application of nanoemulsion is their
use as drug and/or contrast agent nanocarriers, potentially
associated with surface functionalization for targeting appli-
cations.
In this context, the present study actually constitutes
a novel and original application of nanoemulsions, along
with a novel approach for the fabrication of oral modiﬁed
drug-release systems. To summarize, this work presents a
new technology for modifying the drug release of tablets.
Table 1: Tablets composition (g).
Tablets (A) Tablets (B)
Lactose monohydrate 113.8 113.8
Microcrystalline cellulose 222.35 214.45
Corn starch 19.7 27.6
Magnesium stearate 5 5
Colloidal silica 5 5
Talc 2.5 2.5
Carmine red 0.05 0.05
Anhydrous theophylline 131.6 131.6
We describe the structures obtained and their links with the
drug release kinetics, together with the physical processes
involved.
2.MaterialsandMethods
2.1. Materials. Lactose monohydrate was provided by
Danone (Paris, France) and microcrystalline cellulose
(Emcocel 90M) from JRS Pharma (Rosenberg, Germany).
Corn starch, magnesium stearate, talc, and carmine red
were obtained from Cooper (Melun, France). Colloidal silica
(silica dioxide, Aerosil)was purchased from Evonik (Essen,
Germany). Anhydrous theophylline was provided by Fagron
(Saint-Denis, France). Food grade nonionic surfactants
from BASF (Ludwigshafen, Germany), that is, Cremophor
RH40 (polyoxyethylated-40 castor oil, hydrophilic-lipophilic
balance, HLB ∼14–16) were kindly provided by Laserson
(Etampes, France) and used as received. Labraﬁl M1944CS
used as oil phase in the formulation of nanoemulsions
was obtained by Gattefoss´ e (Saint-Priest, France). Finally,
ultrapure water was obtained using the MilliQ ﬁltration
system, Millipore (Saint-Quentin-en-Yvelines, France).
2.2. Methods
2.2.1. Tablets Fabrication. The formulation process and the
composition of tablet followed classical pathways. In this
study, two formulations named (A) and (B) were stud-
ied, diﬀering in the proportions of binding (crosslinked
microcrystalline cellulose) and disintegrating (corn starch)
compounds. The quantities were as reported Table 1.
Once mixed (lactose, cellulose, starch, carmine red, and
theophylline), the powders were homogenized in a Turbula
universal mixer (Basel, Switzerland) during 15min. This
was followed by the addition of magnesium stearate, and
colloidal silica and the powder were further homogenized
in the Turbula mixer for 30 seconds. Next, the powder
is sieved through 1mm meshes sieve and is then pressed
with an alternative Frogerais press (Vitry-sur-Seine, France),
using a 10mm diameter hemispherical punch. The tablets
thus formed are weighted, their hardness was measured
and controlled with a durometer Erweka (Heusenstamm,
Germany), and their friability evaluated with a speciﬁc
apparatus PTF 10E, Pharma Test (Hainburg, Germany). For
both formulation (A) and (B), the aimed tablet weight wasJournal of Drug Delivery 3
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Figure1:Nanoemulsionsformulatedwithlow-energyspontaneous
emulsiﬁcation. Surfactant = Cremophor RH40 oil = Labraﬁl
M1944CS. Hydrodynamic diameter (ﬁlled circles) and polydisper-
sity index (open squared) are plotted against the surfactant/oil
weight ratio (SOR).
ﬁxed at 380mg, and the aimed hardness was 90 and 190N
for the tablets (A) and (B), respectively.
2.2.2. Nanoemulsion Formulation. Lipid nanoemulsions
were formulated according to the low-energy emulsiﬁca-
tion process published elsewhere [33]. The nanoemulsion
dropletswerespontaneouslyformedbybringingintocontact
two phases: (i) the ﬁrst was composed of lipid (liquid
oil, Labraﬁl M1944CS) and a hydrophilic surfactant, both
totally miscible in each other and gently homogenized at
room temperature and (ii) the second phase was aqueous
(pure water). Once these two liquid phases were mixed,
the hydrophilic species were immediately solubilized by the
aqueous phase, inducing the demixing of the oil following
a spinodal decomposition, resulting in the nanoemulsion
droplets. The nanoemulsion properties, that is, size and
polydispersity, have been shown [33] to be closely related
to the relative proportions between oil and surfactant. This
parameter, so-called surfactant oil weight ratio (SOR =
wsurfactant/(wsurfactant +woil)×100) allows the droplet size and
polydispersity index to be precisely controlled. In the present
study, SOR was ﬁxed at 40% as a representative formulation.
Actually, in all the experiments presented here, the SOR
(i.e.,nanoemulsiondropletssize)hasnosigniﬁcantinﬂuence
on the results as well as the release behavior. On the other
hand, the relative proportion of water does not inﬂuence
the nanoemulsion physicochemical properties or their size
and PDI. This parameter is given by SOWR = wsurfactant +
woil/(wsurfactant + woil + wwater) × 100, which was also ﬁxed to
40%. The exact composition of the nanoemulsion used for
coating of tablets is: oil: 24%; surfactant: 16%; water: 60%.
The size distribution and polydispersity of nanoemulsions
were assessed by dynamic light scattering (DLS) using a
Malvern Nano ZS instrument (Malvern, Orsay, France).
The Helium-Neon laser (4mW) was operated at 633nm
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Figure 2:Theophyllinereleaseproﬁlesfromtablets(A)fordiﬀerent
levels of nanoemulsion coating: 2%, 5%, 6.5% and 7.8%, and
without coating (noncoated tablets).
with the scatter angle ﬁxed at 173◦, and the temperature
was maintained at 25◦C. The polydispersity index (PDI)
is a measure of the broadness of the size distribution
derived from the cumulants analysis of DLS. For a single
Gaussian population with standard deviation σ,a n dm e a n
size xPCS, then PDI = σ2/x2
PCS is the relative variance of the
distribution. The PDI discloses the quality of the dispersion,
from values lower than 0.1 for acceptable measurements
and good-quality colloidal suspensions, to values close to
1 for poor-quality samples, either with droplet sizes out
of the colloidal range or with a very high polydispersity.
Measurements were performed in triplicate, before and after
the spray drying process (ﬁltered at 0.45μm in the above
case).
2.2.3. Tablets Nanoemulsion Coating. The tablet coating
was performed in a ﬂuid bed “bottom spray” apparatus,
Innojet Ventilus 2.5 (Steinen, Germany). 50g of tablets are
introduced in the chamber in which is also the rotating
spray nose. The experiment was carried out according to the
following experimental parameters: air ﬂow: 76m3/h; ﬂux:
13%; temperature: 40◦C. The weight increase due to the
coatingisregularlycontrolled,andtheexperimentisstopped
when the desired nanoemulsion weight coating is obtained.
The upper coating level possible reached in these experi-
ments was around 8%.
2.2.4.DrugReleaseProﬁles. Dissolutiontestswereperformed
in an automatized basket apparatus, Dissolutest Caleva BIO-
DIS RRT 9 (Frankfurt, Germany). The basket volume is4 Journal of Drug Delivery
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Figure 3: Theophylline release proﬁles from tablets (b) for diﬀerent levels of nanoemulsion coating: 2%, 5.5%, 6%, and 7.6%, and without
coating (noncoated tablets). The two graphs show the same results with diﬀerent time scale, in order to emphasize the diﬀerent release
regimes arising for 2% and 5% (for which the frontiers between both are indicated by the arrows).
250mL, and the dissolution media was an aqueous solution
of HCl 0.1M, maintained at 37◦C during 2 hours, as
described in the European Pharmacopoeia (7th Ed.) for the
delayed release dosage forms.
Aliquots are collected at regular time intervals ﬁxed
in function of the release kinetics. Then, the theophylline
concentrations, and thus cumulative drug release, are mea-
sured at 288nm by UV spectrophotometry, UV-2401 PC
Schimadzu (Kyoto, Japan).
Before performing the measurements, the samples were
ﬁltered and diluted, which inhibits the absorption of the var-
ious excipients used. In that way, we prevented interference
between the theophylline quantiﬁcation and the absorption
of the components of the nanoemulsions or of the tablets.
Moreover, a blank test was also performed at 288nm in
absence of theophylline to validate of the measurements.
2.3. Scanning Electron Microscope (SEM). The morphol-
ogy of tablets (surface and interior) was evaluated by a
scanning electron microscopy (Philips XL20, University of
Strasbourg, plateforme de microscopie ´ electronique, Institut
de G´ en´ etique et de Biologie Mol´ eculaire et Cellulaire). The
specimensweremountedonthecarbonsupport,coatedwith
a palladium layer and analyzed at 20kV.
3. Results
The ﬁrst results concerns the tablet characterization, notably
the controls described in the European Pharmacopoeia (7th
Ed.).
Table 2: Tablets characterization and Pharmacopoeia controls.
Tablets (A) Tablets (B)
Weight (mg) 383 ±2 382 ±3
Hardness (N) 84.2 ±0.8 177.2 ±0.5
Friability (%) 0.18 ±0.04 0.12 ± 0.05
Desegregation (s) 19 ±41 9 ±2
These results are summarized in Table 2 and validate the
dosage forms, compositions, and formulation processes.
The main diﬀerence between the two formulations arises
in their hardness, and as expected, a higher amount of
disintegrating compound reduces the hardness.
Another aspect of the earlier characterization lies in the
study of the nanoemulsion formulation process. Hydrody-
namic diameter and PDI were measured in function of the
surfactant to oil ratio (SOR) deﬁned above. The results are
reported in Figure 1.
The global proﬁle of the curves appears coherent with
the ones expected for such self nanoemulsifying systems,
with relatively monodisperse size distributions (PDI < 0.2).
Accordingly, the representative formulation selected for the
tablet coating was SOR = 40%, corresponding to dh =
57.9nmandPDI= 0.14.
Once the tablets (A) and (B) coated with the nanoemul-
sion suspension, and at diﬀerent given proportions, the
followup of the theophylline release was performed. These
results are reported in Figures 2 and 3, for the tablets (A) and
(B), respectively.Journal of Drug Delivery 5
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Figure 4: SEM micrographs of the tablets formulation (A). Observations performed on the tablet surface (top) and inside (bottom), for
noncoated tablets and nanoemulsions coated (NE-coated).
It clearly appears that the theophylline release can be
signiﬁcantly modiﬁed by the intrinsic physical properties
of the tablets associated with the lipid coating. In all the
experiments, drug release from tablets (A) (Figure 2)w a s
found to be independent of any coating, resulting in fast
dissolutions within a minute. On the other hand, drug
release from tablets (B) (Figure 3) were very sensitive to
the amount of lipid coating. In addition, the curves for
the coated tablets (B) show a linear release corresponding
to the zero-order kinetics. This regimes, which is followed
by a second nonlinear regime for 2.0% and 5.5%. The
proﬁles are entirely linear up to the full release for higher
coating amount, 6.0 and 7.6%, providing a zero order during
46min and 1h for these examples, respectively. For 2.0%
and 5.5% the release proﬁles show that two regimes follow
one another, one exhibits a zero-order release, while the
other appears as a transitional drug release similar to the
one in noncoated tablets (see details below). Arrows in the
ﬁgure indicate the location of the frontier between both
regimes.
In order to characterize the ﬁne structure on the micro-
metric scale, the tablets were observed by scanning electron
microscopy. The surface and interior of both coated and
uncoated tablets, (A) and (B), were analyzed. The pictures
are reported in the Figures 4 and 5, for the tablets (A) and
(B), respectively.
In both cases (A) and (B), it clearly appears that
the lipid coating creates a “smooth” layer on both the
tablets surface and the tablets inside. The edges generated
by the compression fully disappear after the coating. It
means that the nanoemulsions are very homogeneously
spread onto the available surface and also can penetrate the
microporous tablet matrix during the spray-coating process,
which can both be due to the nanometric scale of such
a dispersed system. Another point lies in the diﬀerence
between the formulations of (A) and (B), where the second
one (B) was found to be more compact. This actually
corroborates their diﬀerence in hardness (see Table 2)
and contributes to explain the fundamental diﬀerences in6 Journal of Drug Delivery
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Figure 5: SEM micrographs of the tablets formulation (B). Observations performed on the tablet surface (top) and inside (bottom), for
noncoated tablets and nanoemulsions coated (NE-coated).
the release proﬁles between both formulations (A) and
(B).
4. Discussion
The main point of this study lies in the new and simple
possibilities oﬀered by lipid nanoemulsions (i) to integrate
the microporous matrix of tablets (corroborated by the SEM
pictures Figure 5), (ii) to homogeneously coat the surface,
and(iii)tocreatealipidbarrierinducingazero-orderrelease
mechanism in the formulation (B). One interpretation of
this zero-order drug release could be the Fickian diﬀusion-
based mechanism, considering that the lipid will create
a “ﬁlter” or a membrane-like barrier against hydrophilic
molecules. As a result, the theophylline molecules leakage
from the tablet followed a linear release behavior as long as
this lipid barrier is intact. This zero-order release process
can be described as a constant regime, also called steady
state diﬀusion. Considering the case of ideal thermodynamic
system having a diﬀusion coeﬃcient D which is independent
from the concentration C, and having an unidimensional
diﬀusion, this diﬀusion regime can be best described by the
Fick’s ﬁrst law
J =
dMt
Sdt
=− D
dC
dx
, (1)
where J is the ﬂux, S the surface of the diﬀusion plane, and x
is the distance of diﬀusion. Accordingly, this unidimensional
equation can easily be adapted for the case of a spherical
drug-delivery system of radius Re,c o m p o s e do fad i ﬀusion-
limiting barrier of thickness Re − Ri, giving the drug mass of
the released Mt in function of time t,a sr e p o r t e di n
Mt =
ReRi ×4πDKC0
Re −Ri
× t ,( 2 )
where K is the partitioning coeﬃcient between the lipid
barrier and water, C0 is the diﬀerence in concentrationJournal of Drug Delivery 7
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Figure 6: Interpretations of the drug release behaviors from Figure 3. Theophylline release from tablets (b), for diﬀerent levels of
nanoemulsion coating: 2%, 5.5%, 6%, and 7.6%, and noncoating tablets.
between the both sides of the lipid barrier. When the
amount of lipid is suﬃcient (e.g., Figure 3 cases 6 and
7 . 6 % ) ,t h i sb a r r i e ra p p e a r st ob es t r o n ge n o u g ht oa l l o w
this linear behavior until the release of all the encapsulated
drug amount. However, for intermediate concentrations (as
observed in Figure 3 cases 2 and 5.5%), after a given time
tα, this diﬀusion-limiting layer is dissolved or disaggregated,
and a second phase of drug release occurs. This phase
follows a “nonsteady state” diﬀusion regime for which the
concentration gradient varies with time. This process is
describedinthegeneralcasebytheFick’secondlaw,reported
below:
dC
dt
= D
d2C
dx2 . (3)
In the case of a spherical drug delivery matrix, this
equation is adapted as shown below:
Mt
M∞
= 6

D(t −tα)
πR2
1/2
−
3D(t −tα)
R2 , (4)8 Journal of Drug Delivery
where M∞ is the mass of the drug released at inﬁnite time,
tα is the delay induced by the ﬁrst zero-order release, and
R is the sphere radius. This behavior is also found for the
noncoated tablets, with a lag time tα around 19 seconds
due to the tablet hydration. It is interesting to note that
the zero-order release proﬁles exhibit slopes (i.e., release
speedsquantiﬁedbelow),decreasingwithincreasingamount
of coating lipid. This detail conﬁrms that the diﬀusion-
based mechanism can be a correct interpretation of the
zero-order phenomena compared to the other physical
possible processes, for example, zero-order homogeneous
erosion for which the release speed should be constant in
similar experimental conditions. All the release proﬁles of
the formulation (B) are ﬁtted following these two models,
and schematic illustrations of the mechanisms and tablets
structures are reported in Figure 6.
The main results of a quantitative comparison of the
diﬀerent cases are reported in Table 3.
The theoretical models appear quite well in accordance
with experimental results, which conﬁrms the hypothesis
ventured regarding the structures and the release processes.
The higher the nanoemulsion coating level, the lower the
release speed. If the coated lipid layer is considered globally
constant, this behavior can be attributed to the decrease of
the diﬀusion coeﬃcient D, and thus to the decrease of the
permeability P = DK/(Re −Ri). On the other hand, the time
tα in which this lipid layer is broken up also appears related
to the coating amount. It follows therefrom that tα indicates
the transition between the two diﬀusion regimes (1)a n d
(2) highlighted in Figure 6. The higher the coating amount,
the more stable is the layer, being deﬁnitively stable for the
examples of 6 and 7wt.%. Finally, the last parameter D/R2
characterizing the unsteady-state regimes, shows a gradual
increase between the three ﬁrst cases. As the natural trend
for D is a decrease, the observed increase of D/R2 emphasize
a lowering of R,a n dt h u so fRi with the lipid amount. To
conclude, coating tablets with lipid nanoemulsions results
in the fabrication of a surrounding lipid layer within the
tablet, which is able to limit the drug diﬀusion, similar to
a membrane. With the increase of the lipid coating wt.%,
this layer become thicker and more stable. Compared now to
the hydrophilic matrix discussed above, these systems, made
fromafundamentallydiﬀerenttechnology, appeartopresent
very similar properties.
Asalastremark,letusfocusontheformulation(A).Even
if the coating process and tablet characterization are similar
between(A)and(B),thedrugreleaseproﬁlesdonothaveany
similarities (Figure 2). Compared with the (B), the tablets
(A) show much lower hardness (about half of that of B),
which results in higher porosity. The impossibility to create
an impermeable lipid layer results in identical drug release
proﬁles whatever may be the coating amount. This can also
be observed in the SEM pictures,of thetablet surfaces,which
appear to be more compact and robust in the case of the
formulation (B).
To ﬁnish, such a technology not only appears innovative
under the fundamental point of view, since it is the ﬁrst time
that a zero-order release is obtained with a lipid coating,
but also it appears interesting in term of industrial scaling
Table 3: Experimental parameters obtained from the kinetics drug
release of tablets (B) (see Figure 6). The release speeds reported
(dMt/dt) correspond to the linear diﬀusion regime.
NE-coating v = dMt/dt (10−5g ·s−1) tα D/R2(s
−1)
non-coated — 19s 0.011
2wt.% 38.9 122s 0.236
5.5wt.% 7.6 11min 2.757
6wt.% 4.2 — —
7.6wt.% 3.6 — —
up. On the one hand, the nanoemulsion generation method
is extremely simple and can be performed only by mixing
two liquids, and on the other hand, the method also appears
cost eﬀective since it avoids using very speciﬁc and expensive
polymers for results which can be comparable.
5. Conclusion
This study presents for the ﬁrst time the application of
lipid nanosuspensions as coating agent for inducing a zero-
order hydrophilic drug-release proﬁle. To date, this result
was only obtained by using hydrophilic polymeric matrix,
and we showed here the proof of concept of this new
technology. Lipid nanoemulsions generated by spontaneous
nanoemulsiﬁcations were used as coating agent. The lipid
nanodroplets were able to enter the lipid matrix, to coat the
microporous network of the tablet, and to ﬁnally create a
layer acting as barrier against the diﬀusion of hydrophilic
drugs. This technology is simple, cost eﬀective, and eﬃcient,
and we believe that it can open new perspectives for the
fabrication of pharmaceutics and oral modiﬁed release-
dosage forms.
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